We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Helix Acquisition Corp | NASDAQ:HLXA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.25 | 12.71 | 13.70 | 0 | 01:00:00 |
FORM 4
☐
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Chen Bihua | 2. Issuer Name and Ticker or Trading Symbol MoonLake Immunotherapeutics [ MLTX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person | |
Rule 10b5-1(c) Transaction Indication
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Class A Ordinary Shares | 3677100 | I | See Footnotes (1) | |||||||
Class A Ordinary Shares | 6/26/2023 | P | 1481 | A | $36.91 (2) | 3678581 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 3755 | A | $38.18 (4) | 3682336 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 10593 | A | $39.17 (5) | 3692929 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 38623 | A | $39.87 (6) | 3731552 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 50642 | A | $41.03 (7) | 3782194 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 61042 | A | $42.12 (8) | 3843236 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 66087 | A | $43.3 (9) | 3909323 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 31558 | A | $44.23 (10) | 3940881 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 10946 | A | $44.93 (11) | 3951827 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 37783 | A | $48.93 (12) | 3989610 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 59787 | A | $49.82 (13) | 4049397 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 17662 | A | $50.77 (14) | 4067059 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 8697 | A | $52.01 (15) | 4075756 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 4725 | A | $52.81 (16) | 4080481 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 21823 | A | $53.98 (17) | 4102304 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 18949 | A | $54.92 (18) | 4121253 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 1453 | A | $55.83 (19) | 4122706 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 1894 | A | $56.89 (20) | 4124600 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 295 | A | $57.63 (21) | 4124895 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 1302 | A | $58.98 (22) | 4126197 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 417 | A | $60.21 (23) | 4126614 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 136 | A | $62.2 (24) | 4126750 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 139 | A | $63.85 (25) | 4126889 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 95 | A | $64.44 (26) | 4126984 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 16 | A | $65.32 | 4127000 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 15 | A | $70.62 | 4127015 | I | See Footnotes (3) | ||
Class A Ordinary Shares | 6/26/2023 | P | 85 | A | $72.46 (27) | 4127100 | I | See Footnotes (3) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Chen Bihua C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON, MA 02116 | X |
Signatures | ||
/s/ Bihua Chen | 6/28/2023 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Helix Acquisition Chart |
1 Month Helix Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions